Technically Speakin...
Health Care: Health Services
BioMimetic Therapeutics Inc. (BMTI: NASDAQ)
$2.49 -0.03 | -1.19%
06/01/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -33.19M | -33.94M | -21.16M | -8.00M |
| Operating Gains/Losses | 0.00 | 311.00 | 32.07K | -39.30M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -803.55K | 213.59K | 1.16M | 1.53M |
| (Increase) Decrease in Inventories | -1.27M | -1.21M | 217.68K | -474.86K |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -508.32K | 1.48M | -4.31M | 2.04M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | -1.25M |
| (Increase) Decrease In Other Working Capital | -971.19K | -971.19K | -971.19K | -973.85K |
| Other Non-Cash Items | 6.69M | 4.27M | -1.75M | 16.48M |
| Net Cash From Continuing Operations | -28.65M | -27.28M | -22.89M | -25.74M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -28.65M | -27.28M | -22.89M | -25.74M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 1.90M | 3.44M |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 10.60M |
| Purchases of Property, Plant & Equipment | -2.52M | -1.14M | -2.82M | -4.52M |
| Acquisitions | 0.00 | 0.00 | 10.00M | 29.82M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -61.88M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 194.22K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 35.29M | -28.39M | 41.09M | -22.35M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 39.10M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 314.54K | 45.83M | 25.01M | 1.06M |
| Repayment of Long-Term Debt | -78.66K | -73.44K | -39.12M | -17.35K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | -73.36K | 0.00 |
| Net Cash From Financing Activities | 235.88K | 45.76M | -14.19M | 40.14M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 6.87M | -9.92M | 4.01M | -7.95M |
Portfolios with BMTI
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- Usertest
- ContributorBarron's Activist Stocks 12...
- Userjcweddell Portfolio 1
- Userrazzmazz Portfolio 1
- ContributorBarron's Activist Stocks 7-...
- ContributorBarron's Insider Purchases ...
- Useramarmaharaj Portfolio 1
- UserGet this thing started
- UserBREAKOUTS2008
Latest BMTI Headlines from TheStreet
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.27.11 | 04:07 pm
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.19.11 | 12:07 pm
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.11.11 | 11:07 am
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.01.11 | 12:07 pm
- BioMimetic Stock Hits New 52-Week Low (BMTI) 06.23.11 | 11:06 am
- BioMimetic Stock Hits New 52-Week Low (BMTI) 06.08.11 | 12:06 pm
- BioMimetic Stock Falls On Unusually High Volume (BMTI) 05.13.11 | 10:05 am
- BioMimetic Stock Gaps Down On Today's Open (BMTI) 05.10.11 | 09:05 am
- Insiders Buy and Sell RealD IPO 07.20.10 | 09:07 am
- Stock Offerings: First of Long Island 07.15.10 | 09:07 am
Press Releases for BMTI
- BioMimetic Therapeutics, Inc. Reports First Quarter 2012 Earnings Results - Business Wire 05.09.12 | 04:05 pm
- BioMimetic Therapeutics, Inc. To Report First Quarter 2012 Financial Results On May 9 - Business Wire 05.07.12 | 11:05 am
- BioMimetic Therapeutics, Inc. Reports Fourth Quarter And Year-End 2011 Earnings Results - Business Wire 03.13.12 | 04:03 pm
- BioMimetic Therapeutics, Inc. To Report 2011 Fourth Quarter And Year-End Financial Results On March 13 - Business Wire 03.09.12 | 02:03 pm
- BioMimetic Therapeutics, Inc. To Introduce Augmatrix™ Biocomposite Bone Graft Product Line At AAOS - Business Wire 02.08.12 | 09:02 am
- BioMimetic Therapeutics, Inc. To Highlight Product Development Activities At ORS And AAOS Meetings - Business Wire 02.06.12 | 04:02 pm
- BioMimetic Therapeutics, Inc. To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire 01.10.12 | 11:01 am
- BioMimetic Therapeutics Announces Approval To Market GEM 21S® In The European Union - Business Wire 01.03.12 | 04:01 pm
- BioMimetic Therapeutics Receives Augment® Bone Graft PMA Response Letter From FDA - Business Wire 01.03.12 | 04:01 pm
- BioMimetic Therapeutics, Inc. Reports Third Quarter 2011 Earnings Results - Business Wire 11.08.11 | 04:11 pm
Partner Headlines for BMTI
- Speculative Biotech: A Speculation Trader's Dream and Nightmare - Seeking Alpha 11.03.11 | 09:11 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Morning Market Losers (BMTI, NSPH, HEAT, PAL) - Benzinga 05.10.11 | 09:05 am
- 9 Healthcare Companies Expecting May Catalysts - Seeking Alpha 05.04.11 | 08:05 am
- BioMimetic: What the Bulls Are Seeing - Seeking Alpha 03.18.11 | 08:03 am
- Early-Market Movers: Vivus, Amedisys - Fox Business 07.13.10 | 09:07 am
